Wed, Jan 28, 2015, 2:32 AM EST - U.S. Markets open in 6 hrs 58 mins

Recent

% | $
Quotes you view appear here for quick access.

Novadaq Technologies Inc. Message Board

buzzybob 17 posts  |  Last Activity: 6 hours ago Member since: Mar 16, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    earnings

    by vonpezel Jan 26, 2015 4:07 PM

    My thought in the past, as now, is that the trials and tribulations of the Lifecell saga will continue to recede in importance as PINPOINT and LUNA skyrocket. Spy Elite is important but it is an open surgery tool and therefore will tend fade going forward as techniques advance.

  • Reply to

    earnings

    by vonpezel Jan 26, 2015 4:07 PM
    buzzybob buzzybob 19 hours ago Flag

    Hi Pezel-

    Last year the company announced on January 27th for the earnings release on February 6th. I'll defer any concern for a few days.

    It will be interesting to hear how they field questions about the Lifecell numbers. This isn't the first time there has been a surprise. The intra-quarter sales and inventory levels of their former partner seem to have been completely opaque to Novadaq until the end of each quarter. Still, Arun had to know Lifecell would have zero motivation to promote SPY Elite in what was for them a dead-end quarter.

    Regards, Buzz

  • Seeking Alpha article reiterates a positive long term outlook and points to Lifecell's lackluster sales results (understandable) for the short term woes. Joining is necessary for access.

  • NOVADAQ presents at J.P. Morgan Healthcare Conference
    Tuesday, January 13, 2015 11:30 am (8:30 am PST)
    Webcast provided

    An explanation of the quarterly results may be interesting.

  • Reply to

    Piper Jaffray 26th Annual Healthcare Conference

    by buzzybob Dec 3, 2014 6:41 AM
    buzzybob buzzybob Dec 4, 2014 3:55 PM Flag

    This was billed a fireside chat and much time was devoted to what was already known by long timers - an introduction to SPY technology is and how it is generally applied to surgical procedures and wound care. Also covered was the partnership history with Lifecell and Intuitive. The no-slide format didn’t lend itself to a hard numbers presentation, as some others have in the past, and as such may have been perceived as soft.

    Some time was spent on the Lifecell handover, which was characterized as having gone well. Novadaq’s SPY Elite sales staff are now certified and have the accounts. Some former Lifecell revenue will be booked this quarter, all next quarter. Gross margins here will go above 65% beginning next year.

    What was new was the emphasis on LUNA and how it is used in the wound care setting to guide physician to the proper mode (and timing) of treatment (e.g. amputation, oxygen therapy, peripheral vessel stents, surgery) and in doing so saving much suffering, effort, and a lot of money. Arun seemed elated with the new relationship with the Serena wound care group.

  • Novadaq is presenting on Wednesday, December 3, 2014 at 11:30 AM ET. Webcast will be available at company's site, under investors section, events.

  • Reply to

    Revenues and procedures

    by buzzybob Nov 19, 2014 11:57 AM
    buzzybob buzzybob Nov 20, 2014 10:19 AM Flag

    Arun again mentioned in the Canaccord talk that they would hit their 40% growth target for 2014. He also emphasized that the recurring revenue for EACH machine will grow from current levels. This will have a multiplicative effect on revenues beyond mere capital sales growth.

  • During the Stifel investor talk on 11/18, Arun made the comment that fourth quarter sales were on course to push total 2014 revenues to the 40% growth mark. Analysts currently estimate revenues for the quarter will come in at $15.3M (a large jump up from the last one’s $12.1M, actual). Hitting that number would result in the 40% yearly growth target being met.

    One additional boost may be that as of November 30th the revenues formerly split 50/50 with Lifecell will all be headed for Novadaq’s top line.

    Procedure growth has started to gain traction. As noted in last quarter’s financial results news release procedures were up 47% YOY and 22% QOQ (if annualized this would be 122% growth). For charts see my investor village posts.

    Regards, buzzybob

  • Reply to

    Investor Day Eyewitness Report

    by vonpezel Nov 17, 2014 8:47 PM
    buzzybob buzzybob Nov 18, 2014 12:29 PM Flag

    The CMS comment is an eye-opener. I knew they were fining some hospitals for excessive readmissions for certain conditions and looking to expand, but this sound like something new. Did you get any further details?

  • Reply to

    Upcoming events

    by e11ndofwar Nov 13, 2014 6:46 AM
    buzzybob buzzybob Nov 17, 2014 1:22 PM Flag

    It's a long series of presentations with music interludes inserted at the breaks.

  • Reply to

    Upcoming events

    by e11ndofwar Nov 13, 2014 6:46 AM
    buzzybob buzzybob Nov 17, 2014 9:49 AM Flag

    Investor Day is today at 10:00am ET.

  • Reply to

    very odd trade

    by e11ndofwar Nov 8, 2014 7:19 AM
    buzzybob buzzybob Nov 8, 2014 11:18 AM Flag

    I doubt if this was something other than an prearranged agreement between two trading entities for an open market sale of X shares at Y price at time Z. Sometimes you see this during normal trading hours with little or no change in equity price but with a huge number of shares exchanged.

  • buzzybob buzzybob Nov 7, 2014 9:41 AM Flag

    I am not surprised; the spreads on this stock can be large at times. This morning just after the start of trading for a while the bid was 14.43 and the ask 14.95. The market makers seem to be falling down on the job!

  • Reply to

    anderson gordon

    by e11ndofwar Nov 6, 2014 6:24 AM
    buzzybob buzzybob Nov 6, 2014 3:07 PM Flag

    All I know is that the figures added up for the deferred royalty payment (some of the following from a previous post):

    A figure of $200,000 of royalties was stated as being deferred until FDA clearance. Also mentioned was a total of "about 90" total Firefly systems shipped. Further, 53 were royalty-paid Si systems. Let's round the the remainder to 40 Xi systems. Under the agreement, Novadaq receives $15,000 per unit but only $5,000 is royalty. 40 X $5,000 = $200,000 in royalties.

  • Reply to

    anderson gordon

    by e11ndofwar Nov 6, 2014 6:24 AM
    buzzybob buzzybob Nov 6, 2014 1:14 PM Flag

    Other than the SA article, I remember a mention of it in a JMP report listed in biotuesdays. YH doesn't allow my links. See my posts on Investor village.

  • Reply to

    anderson gordon

    by e11ndofwar Nov 6, 2014 6:24 AM
    buzzybob buzzybob Nov 6, 2014 12:17 PM Flag

    Endo, I thought we hashed this out in the discussion of the Seeking Alpha article of around Sept 4 (no longer available to mere mortals). If I recall correctly, the payment to Novadaq for a Firefly unit is an amazingly low $15k of which $10k is purchase price and $5k is royalty. The royalty was the only thing defered from q2 to q3. Corrections welcomed.

    This is why I'd like to see the Novadaq/Intuitive agreement be renegotiated sooner rather than later.

  • Reply to

    Conference call

    by mojo3176 Nov 4, 2014 5:24 PM
    buzzybob buzzybob Nov 5, 2014 6:12 PM Flag

    I can't say I was totally ecstatic with this quarter's Microcutter sales. However, comparing it to the previous one, it still had a 37% growth Q-to-Q or an annualized rate of 248% (though not having the mind numbing growth of the last quarter which was 200% q-to-q and 8000% annualized) . Can you say lumpy?

    I have no problem believing that numbers will be better from here since these latest numbers include the medical sales doldrums of summer. The additional sales personnel and new models of the Microcutter will help.

NVDQ
14.39+0.01(+0.07%)Jan 27 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Apple Inc.
NASDAQTue, Jan 27, 2015 4:00 PM EST
Microsoft Corporation
NASDAQTue, Jan 27, 2015 4:00 PM EST
Box, Inc.
NYSETue, Jan 27, 2015 4:01 PM EST